Luqing Zhao Selected Research

Luqing Zhao Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 11/2011
4	Inflammation (Inflammations) 06/2022 - 08/2017
4	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2016
4	Carcinogenesis 01/2021 - 11/2011
4	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2016
4	Neoplasm Metastasis (Metastasis) 01/2020 - 06/2015
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2022 - 01/2017
3	Colitis 06/2022 - 01/2021
3	Nasopharyngeal Carcinoma 01/2016 - 10/2013
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2021 - 01/2016
2	Dyspepsia (Indigestion) 03/2020 - 03/2013
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2016
2	Diarrhea 01/2016 - 09/2015
1	Ulcerative Colitis 01/2021
1	Hypersensitivity (Allergy) 03/2020
1	Metaplasia 01/2020
1	Herpes Zoster 01/2020
1	Diabetes Complications 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018
1	Stroke (Strokes) 01/2017
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Adenoma (Adenomas) 01/2016
1	Squamous Cell Carcinoma of Head and Neck 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Glioblastoma (Glioblastoma Multiforme) 01/2016

Drug/Important Bio-Agent (IBA)

6	Biological ProductsIBA 01/2021 - 07/2013
6	MicroRNAs (MicroRNA)IBA 01/2016 - 11/2011
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2014
5	Therapeutic UsesIBA 01/2021 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2011
3	CateninsIBA 01/2021 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 06/2022 - 01/2021
2	EstersIBA 06/2022 - 01/2021
2	6-methyladenineIBA 01/2021 - 01/2021
2	MicellesIBA 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2020
2	Nuclear Respiratory Factor 1IBA 06/2015 - 10/2013
1	FlavonoidsIBA 06/2022
1	BoratesIBA 06/2022
1	HydrogelsIBA 06/2022
1	Rutin (Rutoside)IBA 06/2022
1	CytokinesIBA 06/2022
1	GuanosineIBA 06/2022
1	LigandsIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	atezolizumabIBA 01/2022
1	CarcinogensIBA 12/2021
1	Untranslated RNA (Noncoding RNA)IBA 01/2021
1	glycol-chitosanIBA 01/2021
1	BaizhuIBA 01/2021
1	Circular RNAIBA 01/2021
1	BerberineIBA 01/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	ChitosanIBA 01/2021
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2021
1	PowdersIBA 01/2021
1	ProdrugsIBA 01/2021
1	QuercetinIBA 01/2021
1	high iron diamine-alcian blueIBA 01/2020
1	Myosin Light Chains (Myosin Essential Light Chain)IBA 01/2020
1	Aspartic Acid (Aspartate)FDA Link 01/2020
1	Amino Acids FDA Link 01/2020
1	Tryptases (Tryptase)IBA 01/2020
1	Competitive Endogenous RNAIBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Periodic AcidIBA 01/2020
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	7,3'-dihydroxy-4'-methoxyisoflavoneIBA 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	IronIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 12/2018
1	Gefitinib (Iressa)FDA Link 12/2018
1	Lapatinib (GW572016)FDA Link 12/2018
1	Adenosine Triphosphate (ATP)IBA 12/2018
1	InterleukinsIBA 11/2018
1	Cell Adhesion MoleculesIBA 09/2017
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2017
1	IntegrinsIBA 09/2017
1	Cadherins (E-Cadherin)IBA 09/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017
1	Neuroprotective AgentsIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 05/2016
1	tongxie-yaofangIBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Lysophosphatidic Acid ReceptorsIBA 01/2016
1	sodium-hydrogen exchanger regulatory factorIBA 01/2016

Therapy/Procedure

4	Therapeutics 01/2022 - 11/2011
2	Radiotherapy 06/2015 - 07/2013
1	Immunotherapy 01/2022
1	Phytotherapy (Herbal Therapy) 01/2017
1	Precision Medicine 01/2016